薬理学は,新興の病原体を治療するために,抗ウイルス薬として薬物の再定位という課題を克服するのにどのように役立つのでしょうか? その例として,Covid-19が挙げられます

Inès Ben Ghezala¹, Nathan Peiffer-Smadja^2,3, Caroline Solas^4,5

¹Inserm, CIC 1432, Clinical Investigation Center, Clinical Epidemiology/Clinical Trials Unit, University Hospital, Dijon, France.

Clinical and translational science

|February 16, 2026

まとめ

COVID-19に対する薬物の再利用は,薬理学的な問題と欠陥のある試験のために失敗しました. 将来のパンデミックへの備えには,統合されたPK/PD評価と,効果的な治療法のための標的化された抗ウイルス開発が必要です.

科学分野:

薬理学薬理学とは
感染症感染症は感染症です.
ドラッグ開発ドラッグ開発

背景:

COVID-19のパンデミックは,新しい病原体に対する迅速な治療開発の必要性を強調しました.
薬物の再利用はSARS-CoV-2に対して広範に調査されたが,限られた成功を収めた.

研究の目的:

COVID-19に対する薬剤の有効性を阻害する薬理学および方法論的要因を批判的に見直す.
将来のパンデミック対策と医薬品開発のための教訓を特定する.

主な方法:

アジトロマイシンとヒドロキシクロロキンを中心に,再利用薬に関する既存の文献のナレーションレビュー.
薬物動力学 (PK) と薬物動力学 (PD) の制限,臨床前モデル,臨床試験設計の分析.

主要な成果:

再利用された薬物の有望なインビトロ抗ウイルス作用は,しばしば臨床効果に転じることが出来ませんでした.
主な制限には,口腔での生物利用性の低下,肺組織における低濃度,不適切な臨床前モデルが含まれていました.
臨床試験は,不適正なエンドポイント,比較対象,そして不十分なPK/PDの検討によって妨げられました.

結論:

成功したCOVID-19の抗ウイルス薬は,主に新規または未承認であり,標的型抗ウイルス開発の価値を強調しています.
将来のパンデミック対策には,統合されたPK/PD評価,関連するモデル,そして厳格な試験設計が必要です.
協調された世界的な研究と証拠に基づいた戦略は,効果的なパンデミック対策に不可欠です.

キーワード:

さらに関連する動画

11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

14.5K

12:02

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

14.6K

関連する概念動画

01:29

Microorganisms in Medicine and Therapeutics

1.2K

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

1.2K

01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

01:10

Retrovirus Life Cycles

49.8K

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...

49.8K

01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

278

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...

278

01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...

01:26

Drug Discovery: Overview

12.0K

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...